TRUSTED BY


of Healthcare workers are using generative AI without official authorization, raising concerns about compliance and data integrity. [1]
up to 70% of development costs can be cut by AI, drastically reducing the financial burden of drug discovery and increasing the chances of success. [2]
public Investment in AI for Healthcare underlines the global commitment to fostering innovation and improving health outcomes, according to AIS. [3]
Biolevate ensures data accuracy, regulatory compliance, and faster time-to-market for new therapies through integrated security and scalable solutions that enable companies to stay competitive globally.
References
[1] Salesforce, 2023, https://www.salesforce.com/news/stories/ai-in-healthcare-survey/
Copyright © Biolevate 2024.




